COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 151 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,002 | +4.0% | 2,103 | 0.0% | 0.00% | – |
Q2 2023 | $45,193 | +90286.0% | 2,103 | 0.0% | 0.00% | – |
Q1 2023 | $50 | -10.7% | 2,103 | -13.2% | 0.00% | – |
Q4 2022 | $56 | -99.9% | 2,423 | 0.0% | 0.00% | – |
Q3 2022 | $43,000 | +2.4% | 2,423 | +1.4% | 0.00% | – |
Q2 2022 | $42,000 | +366.7% | 2,390 | +443.2% | 0.00% | – |
Q1 2022 | $9,000 | -89.5% | 440 | -90.8% | 0.00% | -100.0% |
Q4 2021 | $86,000 | -45.2% | 4,799 | -39.7% | 0.00% | 0.0% |
Q3 2021 | $157,000 | +946.7% | 7,955 | +1183.1% | 0.00% | – |
Q2 2021 | $15,000 | 0.0% | 620 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | +25.0% | 620 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | -81.5% | 620 | -80.1% | 0.00% | -100.0% |
Q3 2020 | $65,000 | +400.0% | 3,112 | +332.2% | 0.00% | – |
Q2 2020 | $13,000 | -7.1% | 720 | -16.8% | 0.00% | – |
Q1 2020 | $14,000 | -22.2% | 865 | 0.0% | 0.00% | – |
Q4 2019 | $18,000 | -81.6% | 865 | -89.8% | 0.00% | -100.0% |
Q3 2019 | $98,000 | – | 8,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |